After NEDD4L overexpression, the viability of both U87-MG and M059K cells was significantly and dose-dependently decreased (Fig 4F), suggesting that NEDD4L acts as a tumor suppressor in glioma progression. Here, NEDD4L is linked to central nervous system cancer.